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Cell-free preparations from rat ~lymo~honuclear leukocytes and skin were found to catalyze the reduction of 12-keto-5,8,10,14-eicosate~~oic 
acid (1ZKETE) to 12-hydroxyeicosatetraenoic acid (12-HETE). The reductase activity was associated with the microsomal fraction and showed 
a marked preference for NADH over NADPH as reducing cofactor. Characterization of the reaction product by chiral phase HPLC of the methyl 
ester derivative indicated that 12-KETE reduction generated ahnost exclusively 12(S)-HETE. The results demonstrate that rat skin and leukocyte 
microsomes possess an NADH-dependent 12-KETE reductase activity that forms 12(S)-HETE as a major product. The identification of stereoselec- 
tive IZKETE reductases provides a basis for further defining the role these enzymes may play in the regulation of 12-KETE levels and in the 
protection against degradation of 12-KETE to the pro-in~ammatory 12(R)-HETE by selectively generating 12-HETE of the S ~nfi~ation. 
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1, INTRODUCTION 
Recent studies have led to the identification of 
12-ketoeicosatetraenoic a id (IZKETE) as a metabolite 
of the 12-lipoxygenase pathway of arachidonic acid ox- 
idation 11-31. This carbonyl derivative has been shown 
to be s~thesized by human platelets and Ap~ysiu ner- 
vous tissue after incubation with arachidonic acid [I ,2]. 
In these systems, 12-KETE appears to derive from the 
12-HPETE product of 12-lipoxygenase, either by 
nonenzymatic degradation or subsequent metabolism 
by lipoxygenases and hemoproteins [3]. 
With the exception of the neurons of the marine 
mollusk Aplysia where lZKE?TE appears to mediate 
some of the responses to histamine [2], little is known 
about the biological activity and the metabolism of this 
eicosanoid. Enzymatic reduction of 1ZKETE to a mix- 
ture of 12(S)- and 12(R)-HETE has been demonstrated 
using rat liver microsomes [4]. This result indicates that 
IZKETE may be a precursor of a pro-inflammatory 
mediator since 12(R)-HETE has been shown to func- 
tion as a neutrophil chemoattractant [5-71. To further 
investigate the role IZKETE reductases may play in the 
regulation of 1ZKETE levels or in the generation of 
12(S)- or 12(R)-HETE, we have examined the tissue 
distribution and the stereochemistry of the reaction 
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product of these enzymes. In the present com~unica- 
tion, we report the identification of 12-KETE reduc- 
tases which selectively convert 12-KETE to 
12(S)-HETE. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Synthetic 12(S)- and 12(R)-HETE were prepared as previously 
described [8]. 12-KETE was prepared by oxidation of 12-HETE and 
purification by silica gel chromatography and RP-HPLC [4]. 
2.2. Pre~ration of s~beeltu~ur fractions 
The microsomal fraction from rat peritoneal polymorphonuclear 
@MN) leukocytes (100000 x g pellet) was prepared as previously 
described [9]. Dorsal skin was excised (< 1 mm thickness) from shav- 
ed adult male rats killed by CO2 inhalation. The tissue was 
homogenized (4“C) using a Polytron in 20 mM Tris-HCl, pH 7.5, 
0.25 M sucrose, 0.5 mM EDTA, 0.1 mM EGTA and 0.5 mM 
dithiothreitol (10 ml/g of tissue). Cell debris were removed by cen- 
trifugation at 1000 x g for 20 min and the supematant centrifuged 
at loo00 x g for 20 min. The resulting supernatant was further cen- 
trifuged at 1OOOCO x g (1 h) to pellet the microsomal fraction which 
was resuspended in Tris-HCl, pH 7.5, containing 5 mM MgCl2. Pro- 
tein contents were determined using the procedure of Lowry et al. 
[lo], using bovine albumin as standard. 
2.3. Assay of 12-KETE reductase activity 
The incubation mixture for 12-KETE reductase assays contained 
20,uM 12-KETE, 0.5 mM NADH or NADPH, 50 mM Tris-HCl, pH 
6.3, and l-2 mg of protein in a final volume of 200 ~1. The mixture 
was incubated at 32’C for 15 or 30 min and the reaction was stopped 
by the addition of 800 pl of diethyl ether/methanol/citric acid 1 M 
(30:4: 1). The suspension was clarified by centrifugation and the 
supematant was concentrated by evaporation under NZ and 
resuspended in methanol for HPLC analysis to resolve 12-KETE 
from the 12-HETE product [4]. RP-HPLC was performed on a CIE 
NovaPak column (Millipore) in methanol/water/acetic acid 
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(75 : 25 :0.01) at a flow rate of 1 ml/min. For the determination of the 
stereochemistry of the reaction product, the eluting material cor- 
responding to the 12-HETE peak was concentrated under reduced 
pressure and derivatized to the 12-HETE methyl ester with etheral 
diazomethane. 12(S)- and 12(R)-HETE methyl esters were resolved 
by HPLC on a Bakerbond DNPBG (ionic) chiral column [ 1 l] in hex- 
ane/isopropanol (100:0.5) at a flow rate of 0.5 ml/min. 
3. RESULTS 
3.1. Enzymatic reduction of 12-KETE by rat leukocyte 
and skin microsomes 
Incubation of the microsomal fraction from PMN 
leukocytes with 12-KETE (20 PM) and NADH resulted 
in the formation of a major product that migrates at 
the position of 1ZHETE on RP-HPLC (fig.1). Product 
formation coincided with a decrease in the amount of 
1ZKETE and could not be detected in the absence of 
NADH. A similar reaction was observed using skin 
microsomes, except that this preparation contained a 
higher level of endogenous 12-HETE (fig.2). For both 
systems, the reaction could not be detected using either 
the cytosolic fractions or heat-inactivated (70°C 
30 min) microsomes. 
Further evidence that the reaction product is 
12-HETE was obtained by re-analysis of the HPLC- 
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Fig.1. Reduction of 12-KETE to 12-HETE by microsomes from 
PMN leukocytes. 12-KETE (20rM) was incubated with the 
microsomal fraction (10 mg of protein/ml) in the presence of NADH 
under the conditions of the 12-KETE reductase assay for 0 and 
30 min, prior to the analysis of the reaction products by RP-HPLC. 
purified product using a different solvent system. Both 
the leukocyte and skin microsome reaction products co- 
eluted with synthetic 12-HETE after chromatography 
on a Crs column in acetonitrile/water/acetic acid 
(66: 33 :O.Ol) (results not shown). The UV spectra of 
the compounds showed the characteristic absorption 
for a conjugated diene with a maximum at 
235-236 nm. 
The 1ZKETE reductase activities using 0.5 mM 
NADH and 20 PM 12-KETE were 2 and 0.4 pmol of 
lZHETE/min per mg of protein for the leukocyte and 
skin microsomal preparations, respectively. NADH 
was the most efficient reducing cofactor for both reac- 
tions, with about 10% of the activity being measured 
with NADPH (fig.3). 
3.2. Stereoselectivity of I2-KETE reduction 
The stereoselectivity of 1ZKETE reduction was 
determined by derivatizing the RP-HPLC-purified pro- 
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Fig.2. Reduction of IZKETE to 12-HETE by skin microsomes. 
12-KETE reductase activity was measured under standard conditions 
(10 mg of protein/ml) using NADH as cofactor. RP-HPLC profiles 
are shown for assays performed in the absence of exogenous 
12-KETE (A) or in the presence of 20pM 12-KETE for reactions 
stopped at time = 0 (B) and 30 min (C). 
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Fig.3. Enzyme cofactor specificity of leukocyte 12XETE reductase. 
IbKETE reductase activity was measured using PMN leukocyte 
microsomes (5 mg of protein/ml) in the presence of 0.5 mM NADH 
or NADPH. The formation of 12-HETE was quantitated by 
RP-HPLC. 
Fig.4. Stereochemical nalysis of the 12-HETE product of 12-KETE 
reductases. Reaction products from the leukocyte (A-C) and skin 
reductases (D-F) were purified by RP-HPLC, derivatized to the 
methyl ester and analyzed by chiral phase HPLC. (A) and (D), 
racemic mixture of synthetic 12(R)- and 12(S)-HETE methyl esters; 
(B) and (E), I2-HETE reaction products; (C) and (F), co-injection of 
the racemic mixture of synthetic standards with the derivatized 
reaction products of IZKETE reductases (corresponding to B and E, 
respectively). 
duct (see fig-l) to the methyl ester and resolving the 
12(R)- and 12(S)-HETE methyl esters by chiral phase 
HPLC (fig.4). The chromatogram of 12-HETE methy 
ester from the reaction product of the leukocyte 
12-KETE reductase shows one peak eluting at the posi- 
tion of 12(S)-HETE methyl ester (fig.rlB). This result 
was confirmed by co-injection of the derivatized pro- 
duct with a 1: I mixture of the R and S isomers 
(fig.4C). Replacement of NADH by NADPH in the 
assay did not change the stereoselectivity of reduction 
(data not shown). 
Similar experiments with the 12-HETE reaction pro- 
duct of the IZKETE reductase from skin microsomes 
indicated that 12(S)-HETE was the predominant 
isomer (fig.4E and F). The material analyzed in this 
case contained a significant proportion of endogenous 
12-HETE, which was exclusively of the S configuration 
(data not shown). 
4. DISCUSSION 
The characteristics of the various 12-KETE reductase 
activities reported until now are summarized in table 1. 
The specific activities of the ~crosomal prep~ations 
from rat PMN leukocytes and skin reported in this 
study were two to three orders of magnitude lower than 
that of the liver enzyme [4]. The reactions, however, 
were more selective both for the utilization of NADH 
and the generation of 12(S)-HETE, suggesting that they 
may be catalyzed by different enzymes. In contrast to 
these IZKETE reductases, most of the carbonyl reduc- 
tases are characterized by a cytoplasmic localization 
and a preference for NADPH [12-141. The latter pro- 
perties are also shared by prostaglandin 
9_ketoreductases, although a distinct NADH-selective 
microsomal form has been identified in monkey liver 
[ 131. The relationship between 12-KETE reductase and 
this enzyme or other aldo-keto reductases, which are 
known to exhibit a broad substrate specificity [14], re- 
mains to be investigated. 
The 12-KETE reductase activity could potentially 
play a role in the regulation of IZKETE released in 
response to histamine [2] or arising from degradation 
Table 1 
Summary of the characteristics of 12-KETE reductases from rat 
tissues 
Source Cofactor Specific activity Isomer product 
(pmol/min per mg (S 12(S)-HETE) 
protein) 
Liver NADH 170 70 
NADPH 130 70 
PMN leukocyte NADH 2 >90 
NADPH 0.3 >90 
Skin NADH 0.4 >80 
NADPH <0.05 
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of the 12-HPETE lipoxygenase product [3]. It is 
noteworthy that skin and leukocyte 1ZKETE reduc- 
tases generate predominantly 12(S)-HETE, the isomer 
which has the lower potency in stimulating neutrophil 
functions [5,6] and in inhibiting ATPase activity in the 
cornea [ 151. 12(R)-HETE is often considered as a pro- 
inflammatory mediator since it selectively stimulates 
neutrophil infiltration in the epidermis after topical ap- 
plication to human skin [16] and has been isolated as 
the major 12-HETE isomer from psoriatic scales [17]. 
Further characterization of 12-KETE reductase levels 
and stereoselectivity should contribute to determine if 
this enzyme plays any role in the modulation of 12(S)- 
and 12(R)-HETE synthesis in normal or psoriatic skin. 
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